0RDV Stock Chart & Stats
€8.30
-€0.16(-2.19%)
At close: 4:00 PM EST
€8.30
-€0.16(-2.19%)
Day’s Range― - ―
52-Week Range€6.17 - €9.45
Previous CloseN/A
Volume658.00
Average Volume (3M)21.00K
Market Cap
€5.93B
Enterprise Value€14.73K
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)10.2
Beta0.74
Next Earnings
Nov 10, 2026EPS Estimate
0.25Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.23
Shares Outstanding261,425,100
10 Day Avg. Volume7,623
30 Day Avg. Volume20,996
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.83
Revenue Forecast (FY)€7.64B
Grifols News
0RDV FAQ
What was Grifols, SA’s price range in the past 12 months?
Grifols, SA lowest share price was €6.17 and its highest was €9.45 in the past 12 months.
What is Grifols, SA’s market cap?
Grifols, SA’s market cap is €5.93B.
When is Grifols, SA’s upcoming earnings report date?
Grifols, SA’s upcoming earnings report date is Nov 10, 2026 which is in 99 days.
How were Grifols, SA’s earnings last quarter?
Grifols, SA released its earnings results on Jul 28, 2026. The company reported €0.226 earnings per share for the quarter, missing the consensus estimate of €0.228 by -€0.002.
Is Grifols, SA overvalued?
According to Wall Street analysts Grifols, SA’s price is currently Overvalued.
Does Grifols, SA pay dividends?
Grifols, SA does not currently pay dividends.
What is Grifols, SA’s EPS estimate?
Grifols, SA’s EPS estimate is 0.25.
How many shares outstanding does Grifols, SA have?
Grifols, SA has 261,425,100 shares outstanding.
What happened to Grifols, SA’s price movement after its last earnings report?
Grifols, SA reported an EPS of €0.226 in its last earnings report, missing expectations of €0.228. Following the earnings report the stock price went up 2.339%.
Which hedge fund is a major shareholder of Grifols, SA?
Currently, no hedge funds are holding shares in GB:0RDV
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Grifols Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
10.13%
12-Months-Change
Fundamentals
Return on Equity
2.89%
Trailing 12-Months
Asset Growth
1.63%
Trailing 12-Months
Company Description
Grifols, SA
As a vertically integrated plasma derivative producer, Spain-based Grifols collects plasma and then manufactures and sells plasma-derived products globally. By acquiring Talecris in 2011, Grifols dramatically expanded its plasma-derived product portfolio, and the firm's bioscience business contributed 78% of sales in 2019. Grifols also has smaller segments including diagnostics, hospital supplies, and biosupplies. Diagnostics is now roughly 14% of revenue following the Novartis and Hologic deals.